Corvus Pharmaceuticals Statistics
Total Valuation
CRVS has a market cap or net worth of $68.65 million. The enterprise value is $42.88 million.
Market Cap | 68.65M |
Enterprise Value | 42.88M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
Earnings Date | May 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRVS has 49.04 million shares outstanding. The number of shares has increased by 3.16% in one year.
Shares Outstanding | 49.04M |
Shares Change (YoY) | +3.16% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | 3.89% |
Owned by Institutions (%) | 39.96% |
Float | 34.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.77 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.04.
Current Ratio | 4.07 |
Quick Ratio | 3.96 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.60% and return on invested capital (ROIC) is -58.43%.
Return on Equity (ROE) | -59.60% |
Return on Assets (ROA) | -50.60% |
Return on Capital (ROIC) | -58.43% |
Revenue Per Employee | n/a |
Profits Per Employee | -$965,321 |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.44% in the last 52 weeks. The beta is 1.02, so CRVS's price volatility has been similar to the market average.
Beta (1Y) | 1.02 |
52-Week Price Change | +28.44% |
50-Day Moving Average | 1.95 |
200-Day Moving Average | 1.86 |
Relative Strength Index (RSI) | 28.91 |
Average Volume (30 Days) | 199,090 |
Short Selling Information
The latest short interest is 1.40 million, so 2.85% of the outstanding shares have been sold short.
Short Interest | 1.40M |
Short Previous Month | 1.49M |
Short % of Shares Out | 2.85% |
Short % of Float | 4.06% |
Short Ratio (days to cover) | 5.82 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -23.41M |
Pretax Income | -27.03M |
Net Income | -27.03M |
EBITDA | -26.88M |
EBIT | -27.03M |
Earnings Per Share (EPS) | -$0.56 |
Balance Sheet
The company has $27.15 million in cash and $1.37 million in debt, giving a net cash position of $25.78 million or $0.53 per share.
Cash & Cash Equivalents | 27.15M |
Total Debt | 1.37M |
Net Cash | 25.78M |
Net Cash Per Share | $0.53 |
Equity / Book Value | 38.68M |
Book Value Per Share | 0.79 |
Working Capital | 21.09M |
Cash Flow
In the last 12 months, operating cash flow was -$23.94 million and capital expenditures -$34,000, giving a free cash flow of -$23.97 million.
Operating Cash Flow | -23.94M |
Capital Expenditures | -34,000 |
Free Cash Flow | -23.97M |
FCF Per Share | -$0.50 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRVS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.16% |
Shareholder Yield | -3.16% |
Earnings Yield | -39.37% |
FCF Yield | -34.91% |
Analyst Forecast
The average price target for CRVS is $6.00, which is 328.57% higher than the current price. The consensus rating is "Buy".
Price Target | $6.00 |
Price Target Difference | 328.57% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -33.76% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |